Hot penny stocks... don't get burned
   

Profile for Immunogen, Inc (IMGN)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
Profile for ImmunoGen Inc.  (IMGN) 
$ 5.20      0.34 (+7.00%) Volume: 405.72 k 4:00 PM EDT Sep 5, 2008
Business Description:
The Company is focused on the development of therapeutics for the treatment of cancer using cancer biology, monoclonal antibodies and small molecule cytotoxic or cell-killing, agents.
Address:    128 Sidney Street, Cambridge, MA 02139
Telephone:   
(617) 995-2500
 
Website:   
www.immunogen.com
Facsimile:   
(617) 995-2510
Email:   
info@immunogen.com
Details
CEO:   
Dr. Mitchel Sayare, Ph.D.
Employees:   
210
Market Cap:   
264.09 m
Issue Type:   
Common Stock
Auditor:    audit & Young LLP
Last Audit:    Unqualified
Indices:    Biotechnology, Russell 2000
Industry Classifications
Sector:   
Healthcare
CIK:   
0000855654
Industry:    Drugs
NAICS:    Pharmaceutical Preparation Manufacturing (325412)
QM ID:    Biotechnology (515)
SIC:    Pharmaceutical Preparations (2834)
Profitability
Management Effectiveness
Gross Margin:   
 
Return on Equity:   
 
EBIT Margin:   
-79.50
Return on Capital:   
-49.00
Profit Margin:   
-79.50
Return on Assets:   
-38.40
Share Statistics
Outstanding:   
50.79 m
Float:   
49.8 m
Short Interest:   
4.92 m (as of 8/12/08)
Short Int Ratio:   
18.80
% of Float:   
9.90%
Non-Corp. Insider Hold'gs:   
2.00% (as of 6/1/08)
Bought Prev 3 Mo:   
50.0 k
Sold Prev 3 Mo:   
0
Institution Hold'gs:   
48.00% (as of 7/1/08)
Total Held:   
24.32 m
Institutions:   
72
Bought Prev Mo:   
2.32 m
Sold Prev Mo:   
680.74 k

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia, profiles by Hemscott.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for IMGN stock. Download IMGN report.
Research Report
Get the full report for FREE
Date:Sep 2, 2008
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download IMGN report
  
Example preview: Research report for Immunogen, Inc (IMGN) Research report for Immunogen, Inc (IMGN) Research report for Immunogen, Inc (IMGN) Research report for Immunogen, Inc (IMGN)
   
   
   
Attention: Please help us to improve our services by answering the following poll:



Please Leave a comment to tell us how you think we can improve our services.

Your message:
   
   
   
   
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments
   
   
   
   

SPKL shot up 21%


From: OTC Journal
Added: 22 Sep, 2007

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Immunogen, Inc
Home | Message boards | Newsletters | Latest Comments | VC directory | AIM London Stock Exchange | Canadian stocks | Chinese stocks | Broker Directory
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2008 hotstocked.com - All rights reserved.